Healthcare provider profile · identity verified

Floyd Lee Mcintyre

Family Practice · SOUTH DENNIS, MA · NPI 1538125166

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Pravastatin Sodium	Pravastatin Sodium	408	109
Lisinopril	Lisinopril	248	60
Rosuvastatin Calcium	Rosuvastatin Calcium	227	64
Omeprazole	Omeprazole	203	63
Levothyroxine Sodium	Levothyroxine Sodium	176	42
Amlodipine Besylate	Amlodipine Besylate	170	40
Hydrochlorothiazide	Hydrochlorothiazide	156	46
Gabapentin	Gabapentin	152	31
Metoprolol Succinate	Metoprolol Succinate	133	32
Atenolol	Atenolol	131	33
Lorazepam	Lorazepam	129	27
Clonazepam	Clonazepam	118	14
Oxycodone Hcl	Oxycodone Hcl	116	20
Tamsulosin Hcl	Tamsulosin Hcl	112	35
Pantoprazole Sodium	Pantoprazole Sodium	102	28
Simvastatin	Simvastatin	102	23
Valsartan	Valsartan	98	27
Metformin Hcl	Metformin Hcl	94	28
Duloxetine Hcl	Duloxetine Hcl	92	22
Albuterol Sulfate Hfa	Albuterol Sulfate	91	26
Pregabalin	Pregabalin	91	14
Atorvastatin Calcium	Atorvastatin Calcium	80	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	74	13
Tramadol Hcl	Tramadol Hcl	74	17
Alendronate Sodium	Alendronate Sodium	71	19
Citalopram Hbr	Citalopram Hydrobromide	67	13
Eliquis	Apixaban	67	14
Venlafaxine Hcl Er	Venlafaxine Hcl	67	suppressed
Incruse Ellipta	Umeclidinium Bromide	66	suppressed
Sertraline Hcl	Sertraline Hcl	63	15
Jardiance	Empagliflozin	62	12
Prednisone	Prednisone	60	28
Losartan Potassium	Losartan Potassium	59	15
Alprazolam	Alprazolam	58	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	suppressed
Famotidine	Famotidine	55	14
Furosemide	Furosemide	54	11
Trazodone Hcl	Trazodone Hcl	51	14
Bupropion Xl	Bupropion Hcl	50	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	49	46
Breo Ellipta	Fluticasone/Vilanterol	46	suppressed
Cefdinir	Cefdinir	44	39
Doxycycline Hyclate	Doxycycline Hyclate	44	36
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	42	suppressed
Nabumetone	Nabumetone	42	20
Allopurinol	Allopurinol	40	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	40	11
Ezetimibe	Ezetimibe	39	15
Xarelto	Rivaroxaban	36	suppressed
Amoxicillin	Amoxicillin	35	28
Potassium Chloride	Potassium Chloride	33	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Rybelsus	Semaglutide	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	26
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Glimepiride	Glimepiride	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	20
Aripiprazole	Aripiprazole	27	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	27	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Azithromycin	Azithromycin	24	17
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Terazosin Hcl	Terazosin Hcl	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	15
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Misoprostol	Misoprostol	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Finasteride	Finasteride	21	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Ciclopirox	Ciclopirox Olamine	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Cephalexin	Cephalexin	17	15
Lithium Carbonate Er	Lithium Carbonate	17	suppressed
Ozempic	Semaglutide	17	suppressed
Tiadylt Er	Diltiazem Hcl	17	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Zafirlukast	Zafirlukast	16	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Glipizide	Glipizide	15	suppressed
Penicillin V Potassium	Penicillin V Potassium	15	suppressed
Qulipta	Atogepant	15	suppressed
Risedronate Sodium	Risedronate Sodium	15	suppressed
Digoxin	Digoxin	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	13	13
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	13	suppressed
Topiramate	Topiramate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	12	suppressed
Carvedilol	Carvedilol	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Colchicine	Colchicine	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error